Skip to main content
Internal Medicine
ALL Specialities
ALL Specialities
/
Internal Medicine
CME
COVID-19 Updates
Diseases & Conditions
Asthma
Diabetes
Musculoskeletal Disorders
Obesity
Pain
Rare Diseases
Subspecialties
Addiction Medicine
Adolescent Medicine
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
Multimedia
Audio
Podcasts
Video
Business of Medicine
Conference Coverage
Topical crisaborole boosts quality of life in atopic dermatitis
Publish date:
November 3, 2016
EXPERT ANALYSIS FROM THE EADV CONGRESS
bjancin@frontlinemedcom.com
Pages
« first
1
2
Recommended Reading
New treatments bring hope for severe atopic dermatitis
MDedge Internal Medicine
Sublingual immunotherapy for allergy-related asthma
MDedge Internal Medicine
Atopic dermatitis increases risk of ADHD, comorbidities add to it
MDedge Internal Medicine
Crisaborole’s safety holds up in long-term atopic dermatitis trial
MDedge Internal Medicine
Skin patch testing pinpoints dietary triggers of IBS
MDedge Internal Medicine
Ustekinumab misses primary endpoint in atopic dermatitis
MDedge Internal Medicine
Drugs in the pipeline hold promise for atopic dermatitis
MDedge Internal Medicine
EpiPen cost increases far exceed overall medical inflation
MDedge Internal Medicine
Atopic dermatitis: Pivotal dupilumab results create sensation
MDedge Internal Medicine
Lebrikizumab opens new door in atopic dermatitis therapy
MDedge Internal Medicine
Dermatology
All Specialties
